|
|
Blood, 15 September 2005, Vol. 106, No. 6, pp. 2050-2058.
Prepublished online as a Blood First Edition Paper on June 2, 2005; DOI 10.1182/blood-2005-03-0921.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo
Mark A. Little,
C. Lucy Smyth,
Rashmi Yadav,
Lyn Ambrose,
H. Terence Cook,
Sussan Nourshargh, and
Charles D. Pusey
From The Eric Bywaters Centre for Vascular Inflammation, London, United Kingdom; the Renal Section, Division of Medicine, Imperial College London, Hammersmith Campus, London, United Kingdom; and the Department of Histopathology, Division of Medicine, Imperial College London, Hammersmith Campus, London, United Kingdom.
Systemic small vessel vasculitis is associated with antineutrophil cytoplasm antibodies (ANCAs). While there is mounting in vitro evidence to suggest that ANCAs are capable of enhancing leukocyte-endothelial interactions, no in vivo evidence for this has been provided. In this study a novel rat model of ANCA-associated experimental autoimmune vasculitis (EAV), induced by immunization with human myeloperoxidase (MPO), was used to analyze directly the potential effect of ANCAs on leukocyte-venular wall interactions in vivo as observed by intravital microscopy. These rats developed anti-MPO antibodies directed against rat leukocytes, showed pathologic evidence of small vessel vasculitis, and had enhanced leukocyte adhesion and transmigration in response to the chemokine Gro (CXCL1 [CXC ligand 1]). Passive transfer of immunoglobulin from rats with EAV to naive rats conferred enhanced adhesion and transmigration responses in the recipients. Furthermore, rats with EAV and recipients of ANCA-positive immunoglobulin developed extensive microvascular injury, as manifested by mesenteric hemorrhage, in response to CXCL1. This study provides the first direct in vivo evidence for the ability of ANCAs to enhance leukocyteendothelial interactions and cause microvascular hemorrhage, thereby providing a mechanism by which ANCAs could exert pathogenic effects in systemic vasculitis. (Blood. 2005;106:2050-2058)

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Watching ANCAs work
- Ingeborg M. Bajema
Blood 2005 106: 1889-1890.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
J. A. Gomez-Puerta and X. Bosch
Anti-Neutrophil Cytoplasmic Antibody Pathogenesis in Small-Vessel Vasculitis: An Update
Am. J. Pathol.,
November 1, 2009;
175(5):
1790 - 1798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Gomez-Puerta, J. Hernandez-Rodriguez, A. Lopez-Soto, and X. Bosch
Antineutrophil Cytoplasmic Antibody-Associated Vasculitides and Respiratory Disease
Chest,
October 1, 2009;
136(4):
1101 - 1111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Bedient, M. I. Schwarz, S. D. Groshong, and E. D. Chan
A 45-Year-Old Man With a History of Hepatitis C and Testicular Cancer Presents With Cavitary Lung Lesions and Palpable Purpura
Chest,
October 1, 2009;
136(4):
1168 - 1174.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B Terrier, D Saadoun, D Sene, P Ghillani, Z Amoura, G Deray, B Fautrel, J-C Piette, and P Cacoub
Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides
Ann Rheum Dis,
October 1, 2009;
68(10):
1564 - 1571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Chen and C. G. M. Kallenberg
Novel territory for neutrophils in the pathogenesis of ANCA-associated vasculitides
Nephrol. Dial. Transplant.,
August 19, 2009;
(2009)
gfp419v1.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Kuligowski, R. Y. Q. Kwan, C. Lo, C. Wong, W. G. James, D. Bourges, J. D. Ooi, L. D. Abeynaike, P. Hall, A. R. Kitching, et al.
Antimyeloperoxidase antibodies rapidly induce {alpha}4-integrin-dependent glomerular neutrophil adhesion
Blood,
June 18, 2009;
113(25):
6485 - 6494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Little, L. Smyth, A. D. Salama, S. Mukherjee, J. Smith, D. Haskard, S. Nourshargh, H. T. Cook, and C. D. Pusey
Experimental Autoimmune Vasculitis: An Animal Model of Anti-neutrophil Cytoplasmic Autoantibody-Associated Systemic Vasculitis
Am. J. Pathol.,
April 1, 2009;
174(4):
1212 - 1220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Schreiber, H. Xiao, J. C. Jennette, W. Schneider, F. C. Luft, and R. Kettritz
C5a Receptor Mediates Neutrophil Activation and ANCA-Induced Glomerulonephritis
J. Am. Soc. Nephrol.,
February 1, 2009;
20(2):
289 - 298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Nolan, N. Kalia, G. B. Nash, D. Kamel, P. Heeringa, and C. O.S. Savage
Mechanisms of ANCA-Mediated Leukocyte-Endothelial Cell Interactions In Vivo
J. Am. Soc. Nephrol.,
May 1, 2008;
19(5):
973 - 984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A.F. de Lind van Wijngaarden, L. van Rijn, E. C. Hagen, R. A. Watts, G. Gregorini, J. W. C. Tervaert, A. D. Mahr, J. L. Niles, E. de Heer, J. A. Bruijn, et al.
Hypotheses on the Etiology of Antineutrophil Cytoplasmic Autoantibody Associated Vasculitis: The Cause Is Hidden, but the Result Is Known
Clin. J. Am. Soc. Nephrol.,
January 1, 2008;
3(1):
237 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. M van der Geld, T. Hellmark, D. Selga, P. Heeringa, M. G Huitema, P. C Limburg, and C. G M Kallenberg
Rats and mice immunised with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes
Ann Rheum Dis,
December 1, 2007;
66(12):
1679 - 1682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lionaki and R. J. Falk
Removing Antibody and Preserving Glomeruli in ANCA Small-Vessel Vasculitis
J. Am. Soc. Nephrol.,
July 1, 2007;
18(7):
1987 - 1989.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R.W. Jayne, G. Gaskin, N. Rasmussen, D. Abramowicz, F. Ferrario, L. Guillevin, E. Mirapeix, C. O.S. Savage, R. A. Sinico, C. A. Stegeman, et al.
Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis
J. Am. Soc. Nephrol.,
July 1, 2007;
18(7):
2180 - 2188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Colman, A. Hussain, M. Goodall, S. P Young, T. Pankhurst, X. Lu, R. Jefferis, C. O S Savage, and J. M Williams
Chimeric antibodies to proteinase 3 of IgG1 and IgG3 subclasses induce different magnitudes of functional responses in neutrophils
Ann Rheum Dis,
May 1, 2007;
66(5):
676 - 682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Xiao, A. Schreiber, P. Heeringa, R. J. Falk, and J. C. Jennette
Alternative Complement Pathway in the Pathogenesis of Disease Mediated by Anti-Neutrophil Cytoplasmic Autoantibodies
Am. J. Pathol.,
January 1, 2007;
170(1):
52 - 64.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Schreiber, H. Xiao, R. J. Falk, and J. C. Jennette
Bone Marrow-Derived Cells Are Sufficient and Necessary Targets to Mediate Glomerulonephritis and Vasculitis Induced by Anti-Myeloperoxidase Antibodies
J. Am. Soc. Nephrol.,
December 1, 2006;
17(12):
3355 - 3364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Huugen, J. W. Cohen Tervaert, and P. Heeringa
TNF-{alpha} Bioactivity-Inhibiting Therapy in ANCA-Associated Vasculitis: Clinical and Experimental Considerations
Clin. J. Am. Soc. Nephrol.,
September 1, 2006;
1(5):
1100 - 1107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-J. Ruth, A. R. Kitching, R. Y.Q. Kwan, D. Odobasic, J. D.K. Ooi, J. R. Timoshanko, M. J. Hickey, and S. R. Holdsworth
Anti-Neutrophil Cytoplasmic Antibodies and Effector CD4+ Cells Play Nonredundant Roles in Anti-Myeloperoxidase Crescentic Glomerulonephritis
J. Am. Soc. Nephrol.,
July 1, 2006;
17(7):
1940 - 1949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Morgan, L. Harper, J. Williams, and C. Savage
Anti-Neutrophil Cytoplasm-Associated Glomerulonephritis
J. Am. Soc. Nephrol.,
May 1, 2006;
17(5):
1224 - 1234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Jennette, H. Xiao, and R. J. Falk
Pathogenesis of Vascular Inflammation by Anti-Neutrophil Cytoplasmic Antibodies
J. Am. Soc. Nephrol.,
May 1, 2006;
17(5):
1235 - 1242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Feldmann and C. D. Pusey
Is There a Role for TNF-{alpha} in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis? Lessons from Other Chronic Inflammatory Diseases
J. Am. Soc. Nephrol.,
May 1, 2006;
17(5):
1243 - 1252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Pusey
The Continuing Challenge of Anti-Neutrophil Cytoplasm Antibody-Associated Systemic Vasculitis and Glomerulonephritis
J. Am. Soc. Nephrol.,
May 1, 2006;
17(5):
1221 - 1223.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Little, G. Bhangal, C. L. Smyth, M. T. Nakada, H. T. Cook, S. Nourshargh, and C. D. Pusey
Therapeutic Effect of Anti-TNF-{alpha} Antibodies in an Experimental Model of Anti-Neutrophil Cytoplasm Antibody-Associated Systemic Vasculitis
J. Am. Soc. Nephrol.,
January 1, 2006;
17(1):
160 - 169.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|